CRISPR

Tiny green sprout growing from soil
Biotech

Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal

Chiesi is shelling out $115 million upfront to develop and commercialize ABO-101, a gene therapy for primary hyperoxaluria type 1.
Darren Incorvaia Oct 6, 2025 7:00am
DNA genome CRISPR gene editing

ARPA-H unveils programs to develop custom gene editing therapies

Sep 26, 2025 10:41am
KJ Muldoon graduates from the hospital and heads home for the first time

Center launches with $20M to create CRISPR therapies for kids

Jul 8, 2025 11:59am
Graphic image of someone plucking out a portion of DNA with tweezers symbolizing gene editors

Gene editing leaders call for 10-year ban on heritable edits

May 28, 2025 7:00am
Gene editing therapy patient KJ with Drs Ahrens-Nicklas and Musunuru

Boy with rare disease 'thriving' after 1st custom gene therapy

May 15, 2025 1:00pm
CRISPR Therapeutics

CRISPR Tx sees 80% fall in LDL, triglycerides after in vivo edit

May 7, 2025 10:00am